Looking to publish your next article?
Find the perfect home for your research. Each journal in this portfolio is PubMed indexed, peer-reviewed and fully open access; aiming to serve the academic research community, scientific community and practitioner community.
The below journals have various specialties in:
- Tumor immunology, immunological biomarkers and anticancer therapies with immunotherapies
- Thermal energy-based disease treatment, either clinical studies, biological studies or physics and engineering
- Antibody research and development
- Blood and lymphatic cancer research
- Molecular diagnosis of and targeted molecular or precision therapy for all types of cancer
- Hepatobiliary tumors
- Application of oncolytic viruses for the treatment of cancer
Find out if your institution or country has an open access agreement to publish with us.
OncoImmunology
2019 Impact Factor 5.869
Five-Year Impact Factor 6.255
Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.
International Journal of Hyperthermia
2019 Impact Factor 3.574
Five-Year Impact Factor 3.594
The International Journal of Hyperthermia publishes peer reviewed research and clinical studies on thermal energy-based disease treatments.
Hematology
2019 Impact Factor 1.650
Five-Year Impact Factor 1.406
Publishing original and review articles in the field of general hematology, and interdisciplinary areas of research related to general hematology, including oncology.
mAbs
2019 Impact Factor 4.634
Five-Year Impact Factor 4.981
mAbs publishes antibody research on topics including targets relevant to cancer and immune-mediated disorders, and antibody therapeutics.
Blood and Lymphatic Cancer: Targets and Therapy
A Dove Medical Press journal
This journal focuses on blood and lymphatic cancer research, the identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
Cancer Management and Research
A Dove Medical Press journal
2019 Impact Factor 2.886 (5 year impact 3.000)
This journal focuses on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
OncoTargets and Therapy
A Dove Medical Press journal
2019 Impact Factor 3.337 (5 year impact 3.044)
This journal focuses on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.
Journal of Hepatocellular Carcinoma
A Dove Medical Press journal
2019 Impact Factor 4.655
The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.
Oncolytic Virotherapy
A Dove Medical Press journal
The journal publishes original research, study protocols, reviews, editorials and commentaries on all aspects of oncolytic virology, namely the application of oncolytic viruses for the treatment of cancer.
